BioCorRx Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $99.9K | $-7.0M | $85.8K |
| FY2022 | $0 | $-8.1M | $68.6K |
| FY2023 | — | $-9.8M | $65.2K |
| FY2024 | — | $-12.1M | $88.0K |
| FY2025 | — | $-11.2M | $287.7K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $99.9K | $-7.0M | $85.8K |
| FY2022 | $0 | $-8.1M | $68.6K |
| FY2023 | — | $-9.8M | $65.2K |
| FY2024 | — | $-12.1M | $88.0K |
| FY2025 | — | $-11.2M | $287.7K |